University of Rochester - Clinical Trials Coordination Center (CTCC)

The Clinical Trials Coordination Center (CTCC) operates to foster multi-institutional academic research through the development, management, and reporting of hypothesis-driven, controlled clinical trials.

Under the direction of a dedicated staff of physicians and healthcare professionals specializing in movement disorders, the CTCC has been in operation since 1986, initially to support the National Institute of Health (NIH) sponsored DATATOP (Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism) trial. The CTCC has since grown to support a full array of services essential to clinical trials services for industry, foundations, and government sponsors. The CTCC works in close collaboration with the Department of Biostatistics and Computational Biology at the University of Rochester to provide a complete suite of clinical trials services.

The CTCC is utilized by several multi-center investigator-initiated consortia including the Parkinson Study Group (PSG), the Huntington Study Group (HSG), the NIH Exploratory Trials in Parkinson's Disease (NET-PD), and the Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC) Network. These study groups are comprised of more than 350 academic investigators from the United States, Canada, Europe and Australia. The CTCC is also one of the primary research training sites for a National Institute of Health funded training grant: Experimental Therapeutics in Neurological Disease, R.C. Griggs, PI (Clinical Neuroscience, #NS-07338).